Skip to main content

Data Model Praklinikal NAFLD/NASH Baharu akan Dibentangkan pada ADA 2020

Written by Customer Service on . Posted in Public Companies.

SAN DIEGO, June 10, 2020 (GLOBE NEWSWIRE) — Crown Bioscience hari ini mengumumkan pembentangan data pembangunan model praklinikal NAFLD/NASH baharu dan proprietari. Data akan tersedia di American Diabetes Association (ADA) 80th Scientific Sessions, serta acara maya percuma CrownBio sendiri.
Data baharu ini mengongsikan pembangunan model NAFLD/NASH yang dijana melalui pengubahsuaian pemakanan merentasi himpunan mencit yang bertranslasi tinggi dan model praklinikal NHP CrownBio. Model ini akan mendayakan pembangunan ubat praklinikal yang ditingkatkan NAFLD/NASH, bidang penyakit yang kekurangan terapi yang diluluskan buat masa ini.Berserta poster ADA 2020, CrownBio juga menyokong Hari NASH Antarabangsa yang serentak pada 12hb Jun dengan pembentangan pembangunan model NAFLD/NASH. CrownBio akan menganjurkan acara maya percuma, memberikan akses kepada semua sumber ini, yang boleh didaftarkan di CrownBio.com/ADA20.“Kami komited untuk memajukan dan mempercepat penyelidikan NAFLD/NASH, dengan terus meningkatkan platform kami bagi model bertranslasi tinggi,” kata Dr. Jim Wang, naib presiden kanan penyakit kardiovaskular dan metabolik di CrownBio. “Kami amat teruja kerana dapat berkongsi penyelidikan terkini kami di bidang yang mempunyai permintaan tinggi yang belum dipenuhi ini merentasi pelbagai acara maya inovatif pada bulan Jun ini.”Acara ADA maya CrownBio akan berlangsung dari 12hb hingga 16hb di CrownBio.com/ADA20, dan akan membenarkan perbincangan dengan pasukan penyakit kardiovaskular dan metabolik CrownBio, serta menyemak dan memuat turun pelbagai sumber merentasi bidang penyakit, termasuklah penyakit NAFLD/NASH, diabetes, obesiti, renal dan kardiovaskular.Perihal Crown Bioscience Inc.Crown Bioscience, sebuah syarikat JSR Life Sciences, merupakan sebuah syarikat perkhidmatan penemuan dan pembangunan ubat global yang menyediakan platform translasi untuk memajukan kajian onkologi, keradangan, penyakit metabolisme. Dengan portfolio menyeluruh bagi model berkaitan dan alat ramalan, Crown Bioscience membolehkan pelanggan menyampaikan calon klinikal yang superior. Untuk mendapatkan maklumat lanjut, lawati:https://www.crownbio.comhttps://www.jsrlifesciences.comPertanyaan Media:Crown Bioscience 
 Jody Barbeau
pr@crownbio.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.